Ocean Biomedical
Business Services · Rhode Island, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
55 Claverick St Ste 325, Providence, Rho...Phone Number
(401) 444-7375Website
www.oceanbiomedical.comRevenue
<$5 MillionStock Symbol
OCEAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ocean Biomedical
Ocean Biomedical is working with researchers and research institutions to efficiently move new discoveries from the lab to the clinic, providing the capital and expertise needed to turn novel ideas into transformative medicines. Ocean Biomedical is headquartered in Providence, Rhode Island.Explore more
Ocean Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ocean Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Ocean Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Ocean Biomedical has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Ocean Biomedical launches new products
Congratulate Masked Content for being promoted to Masked Content at Ocean Biomedical
Check out if Ocean Biomedical is spiking on competitors!
Click to see if Ocean Biomedical had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Ocean Biomedical has new funding data
Earning: See what the market has to say on Ocean Biomedical recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Ocean Biomedical
Compare insights from companies similar to Ocean Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ocean Biomedical is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ocean Biomedical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ocean Biomedical.
Ocean Biomedical financials insights
Gather financial insights about Ocean Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Debt
$10M
Share Placement
$10M
Ocean Biomedical Tech Stack
A closer look at the technologies used by Ocean Biomedical
Most Recent Scoops
Funding
Funding
Funding
Initial Public Offering (IPO)
, a biopharma company, plans to raise up to $54.8 million in an initial public offering (IPO) of 3.2 million shares priced between $14 and $17 per share, as previously reported.
Initial Public Offering (IPO)
Ocean Biomedical News & Media
Cancer Immunotherapy Patent Granted in China for Dual-Target Antibody - Stock Titan
Novel bispecific antibody technology targets CHI3L1 and PD1 pathways, potentially revolutionizing cancer immunotherapy. Major IP expansion into Chinese market.Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China
PROVIDENCE, R.I., March 28, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company dedicated to advancing innovative treatments for cancer, infectious diseases, and fibrosis, today announced that the China National Intellectual Property Administration (CNIPA) has granted a notice of grant on patent right for its bispecific antibodies targeting CHI3L1 and PD1, designed to enhance T cell-mediated cytotoxic effects on tumor cells.Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development
Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma InterestOcean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
Providence, RI, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) announced today that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional significant funding from the National Institutes of Health (NIH) to advance their groundbreaking malaria vaccine research. In parallel, recent U.S. Food and Drug Administration (FDA) Guidance on lipid-encapsulated vaccines may offer an expedited development pathway for their innovative approa
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ocean Biomedical
Sign Up For FreeTo access detailed company insights
Ocean Biomedical is working with researchers and research institutions to efficiently move new discoveries from the lab to the clinic, providing the capital and expertise needed to turn novel ideas into transformative medicines. Ocean Biomedical is headquartered in Providence, Rhode Island.... Read More
